Prof. Haiyi Liu 刘海义
Chief Physician, Professor
Department of Colorectal and Anal Surgery, Shanxi Cancer Hospital, Taiyuan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radical surgery for colorectal and anal cancers, laparoscopic minimally invasive colorectal surgery, and sphincter-preserving surgery for low rectal cancer.
Dr. Liu is a Professor, Chief Physician, and Deputy Director of Colorectal Surgery at Shanxi Cancer Hospital. Holding a medical doctorate, Dr. Liu serves as a master's supervisor. Research includes over 30 national papers and 2 SCI articles. Dr. Liu contributed to the book "Sphincter-Preserving Surgery for Rectal Cancer" and specializes in TME sphincter-preserving and laparoscopic techniques.
Professional roles
- Member, Colorectal Cancer Professional Committee, China Anti-Cancer Association
- Member, Colorectal Surgery Group, Oncology Branch, Chinese Medical Association
- Vice Chair and Secretary-General, Colorectal Cancer Professional Committee, Shanxi Anti-Cancer Association
- Editorial Board Member, Chinese Journal of Colorectal Diseases (Electronic Edition)
Name order: in Chinese the family name comes first (Liu Haiyi). Papers usually list the name as Haiyi Liu or Liu H.
Selected publications
25 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- JMIR Cancer, 2026 (senior author): Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer Using Routinely Collected Clinical Data: Multicenter Retrospective Machine Learning Model Development and External Validation Study. PubMed 42842824
- Cell Signal, 2025 (senior author): MACC1 drives metastasis in colorectal cancer by coordinating YKT6-dependent exosome biogenesis and c-Met cargo selection. PubMed 40834974
- World J Surg Oncol, 2025 (senior author): Case report of clostridium difficile infection after rectal resection with ileostomy. PubMed 40025585
- Am J Transl Res, 2023 (senior author): 5-azacytidine inhibits Sox2 promoter methylation during the induction of Thy-1(+)Lin(-) cells into hepatocytes. PubMed 38186987
- J Cancer Res Ther, 2022 (senior author): mFOLFOX4 with or without radiation in neoadjuvant treatment of locally advanced middle and low rectal cancer. PubMed 36647966
- Biomed Res Int, 2022 (senior author): Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients. PubMed 36212713
- World J Gastroenterol, 2011 (first author): Treatment of advanced rectal cancer after renal transplantation. PubMed 21528088
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion